Glycemic and Insulinemic Index Determination of Two Products: Fructilight® and A Fruit Fructo-Oligosaccharides in Sweet Matrix (IGNUT)

April 27, 2011 updated by: CRITT Bio-Industries

Glycemic and Insulinemic Index Determination of 2 Products: Fructilight® and A Fruit Fructo-Oligosaccharides in Sweet Matrix

The aim of the study is to determine glycemic and insulinemic index of 2 sweet syrups : FructiLight® and fruit Fructo-oligosaccharides in sweet matrix compared to glucose.

Study Overview

Detailed Description

12 male and female healthy adults are included in the study. During 5 separated visits subjects consume either 50 g of glucose in water (3 glucose response tests) or portion of syrup supply the equivalent of 50 g of glycaemic carbohydrates (2 syrup response tests).

Experimental sessions last 3 hours with 9 veinous and capillary blood taking. The experimental meals are served at t0 and are consumed between 12 and 15 minutes maximum. At time -5, 0, 15, 30, 45, 60, 90, 120 and 180 minutes, glucose is measured out on capillary blood and insulin is measured out on venous blood.

The glycemic index and Insulinemic index determination of the 2 syrups start by the calculation for each glycemia and insulinemia responses of the AUC over 120 min. The AUC(0-120min) is computed following the FAO recommendation (cf. FAO/WHO 1998), i.e. using the trapezoidal incremental method and not taking into account the area beneath the fasting concentration. then GI and II values expressed in percentage are calculated by dividing the AUC(0-120min) for test syrup products by the AUC(0-120min) for the glucose reference and multiplying by 100.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pays de La Loire
      • Nantes, Pays de La Loire, France, 44000
        • Biofortis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 18 to 50 years (limits included
  • With a BMI between 19 and 25 kg/m² (limits included)
  • Non-smoker
  • Non-menopausal female with reliable contraception for two cycles before the beginning of the study and agreeing to keep it during the entire duration of the study
  • Capable and willing to conform to the protocol and accepting to give his written informed consent
  • Registered to Social Security System
  • Accepting to be registered on the Volunteers in biomedical research file

After biological analysis, the subjects will be included on the following criteria :

  • Fasting blood sugar level < 1,1 g/L
  • Blood sugar level 120 minutes after 75g glucose intake < 1.4 g/L
  • Complete blood count without significant clinically abnormality according to the investigator
  • ASAT < 1,55 µkat/L
  • ALAT < 1,7 µkat/L
  • GGT < 2,55 µkat/L
  • 45 < Creatinine < 104 µmol/L
  • 1.7 < Urea < 8.3 mmol/L

Exclusion Criteria:

  • Known food allergy, in particular to one of the tested products' components or to related products
  • Personal history of hypercholesterolemia, high blood pressure, diabetes or glucose intolerance
  • Renal insufficiency
  • Liver disorders ongoing
  • Gastrointestinal disorders, clinically significant according the investigator
  • Use of medications which could affect lipidic or carbohydrate metabolism
  • Disease or medication with impact on nutrients digestion and absorption
  • Pregnant or breastfeeding women
  • General anaesthetic in the month before the study
  • Presenting a psychological or linguistic incapability to sign the informed consent
  • Refusing to sign the informed consent
  • Under legal protection (guardianship, wardship) or deprived from his rights following administrative or judicial decision
  • Having received, during the last 12 months, indemnities for clinical trial higher or equal to 4500 Euros
  • Impossible to contact in case of emergency
  • Major or medical or surgical event with hospitalization in the last 3 months
  • Taking part in an-other clinical trial or being in the exclusion period of a previous clinical trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Area Under the glycemia Curve over 120 min (AUC 0-120min)
Time Frame: 120 minutes after intake by test
Syrup glycemic response compare to glucose glycemic response. Measure with glucometer at time 15, 30, 45, 60, 90, 120 (and 180 minutes) after the intake of 50g of glucose equivalent from the products (syrup or glucose). AUC(0-120min) calculation is computed following the FAO recommendation (cf. FAO/WHO 1998), i.e. using the trapezoidal incremental method and not taking into account the area beneath the fasting concentration.
120 minutes after intake by test

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Area Under the insulinemia Curve over 120 min (AUC 0-120min)
Time Frame: 120 minutes after intake by test
Syrup insulinemia response compare to glucose insulinemia response. Measure at time 15, 30, 45, 60, 90, 120 (and 180 minutes) after the intake of 50g of glucose equivalent from the products (syrup or glucose). AUC(0-120min) calculation is computed following the FAO recommendation (cf. FAO/WHO 1998), i.e. using the trapezoidal incremental method and not taking into account the area beneath the fasting concentration.
120 minutes after intake by test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

March 1, 2011

Study Completion (Anticipated)

May 1, 2011

Study Registration Dates

First Submitted

April 20, 2011

First Submitted That Met QC Criteria

April 27, 2011

First Posted (Estimate)

April 28, 2011

Study Record Updates

Last Update Posted (Estimate)

April 28, 2011

Last Update Submitted That Met QC Criteria

April 27, 2011

Last Verified

April 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Subscribe